HEARTWARE, INC. HEARTWARE VENTRICULAR ASSIST SYSTEM - PUMP/DRIVELINE; VENTRICULAR (ASSIST) BYPASS
|
Back to Search Results |
|
Model Number 1104 |
Device Problem
Malposition of Device (2616)
|
Patient Problems
High Blood Pressure/ Hypertension (1908); No Consequences Or Impact To Patient (2199)
|
Event Date 06/30/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
This device is used for treatment not diagnosis.The ventricular assist system is indicated for use as a bridge to cardiac trans plantation and destination therapy in patients who are at risk of death from refractory end-stage left ventricular heart failure.The system is designed for in-hospital and out-of-hospital settings.Investigation of this event is pending and a supplemental report will be sent upon its completion.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that the patient experienced prolonged suction events and there was suspected malpositioning of the ventricular assist device (vad).The speed was adjusted.Computerized tomography (ct) scan showed the inflow cannula aiming at the posterior wall and echocardiogram showed the septum was midline.The vad remains in use.No patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
A supplemental report is being submitted for investigation completion.Product event summary: the ventricular assist device (vad) was not returned for evaluation.The reported suction event was confirmed through log file analysis which revealed nine suction alarms logged since on (b)(6) 2020, as well as three low flow alarms logged since on (b)(6) 2020.Of note, it was reported by the site that a computerized tomography scan showed the inflow cannula aiming at the posterior wall.There is no evidence to suggest that a device malfunction caused or contributed to the reported event.Based on the risk documentation, possible causes of the suction and low flow events may be attributed to multiple factors including but not limited to poor vad filling, inappropriate pump rotational speed, thrombus at the inflow cannula / outflow graft, and / or constriction at the outflow graft.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Manufacturer Narrative
|
A supplemental report is being submitted for a correction and additional information.The event description and patient codes sections were corrected to include that the patient experienced hypertension, which was missing from the initial report.Newly received information included onset and treatment information.Investigation of this event is pending and a supplemental report will be sent upon its completion.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was also reported that the patient had uncontrolled hypertension that was indicated to have begun shortly after vad implant.The patient was treated with medication.No further patient complications have been reported as a result of this event.
|
|
Search Alerts/Recalls
|
|
|